Small inaccuracies in volume delivery compound throughout complex workflows, jeopardizing reproducibility and clinical decision-making. In highly regulated sectors like pharmaceuticals and biotechnology, these technical lapses frequently surface as audit findings. To mitigate this risk, labs must move toward standardized qualification, calibration, and performance verification practices that satisfy modern regulatory expectations.
Nicholas Enea, Product Manager at Artel MVS, Nova Biomedical, will host a live session on September 1, 2026, at 11am EDT. The discussion will translate abstract regulatory guidance into actionable strategies for laboratory managers and quality officers. Attendees will examine common compliance pitfalls and learn to implement robust method validation protocols that ensure results remain defensible under the scrutiny of inspectors.





Comments (0)
No comments yet. Be the first!